jRCTs031180248已完成不适用
Intervention study for the effect of Istradefylline on adjustment of Levodopa in Parkinson's Disease (Istra adjust PD)
未提供0 个研究点入组 111 人开始时间: 2019年5月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 111
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- 干预性
- 分配方式
- 随机
- 干预模型
- parallel assignment
- 主要目的
- treatment purpose
- 盲法
- open(masking not used)
入排标准
- 年龄范围
- 30age old over 至 84age old under（—）
- 性别
- All
入选标准
- Current use of levodopa-containing drugs more than
- 300mg/day and less than 400mg/day administered at least
- three times daily
- Patients with wearing-off
- >= 30 to < 85 years of age at the time of registration
- for the study
- Diagnosed as Parkinson's disease based on the
- International Parkinson and Movement Disorder Society
- (MDS)
- Stages <=3 in the ON state for Modified Hoehn and Yahr
- Scale
- Patients who have given written consent if the patient
- has difficulty in writing due to his or her condition,
- a representative may sign the written consent, subject
- to the patient's prior oral consent
排除标准
- Use of Istradefylline in the past
- Current use of an investigational drug (within 4 months
- prior to the registration for the study)
- Patients with dementia or a score of 23 or less on the
- Mini-Mental State Examination (MMSE)
- Patients with a previous history of brain surgery for
- the treatment of Parkinson's disease at the time point
- of the registration
- Current use or plan to administer levodopa/carbidopa
- intestinal gel at the time point of the registration
- Patients with moderate to severe hepatic disorder
- Use of a new anti-Parkinson's disease drugs or change
- in the treatment of anti-Parkinson's disease drugs
- within 14 days prior to the registration for the study
- Current use of a strong inhibitor of CYP3A4
- (Itraconazole, Clarithromycin) within 14days prior to
- the registration of the study
- Female patients who are pregnant, trying to become
- pregnant or nursing (lactating) an infant
- Patients who are in the Investigator's judgment
- unlikely to comply with medical regimens or study
- requirements
结局指标
主要结局
-
Accumulated dose of Levodopa
次要结局
- Additional dose(Week4 until Week36)
- Number of the days to the first additional dose(Week0)
- Change in the dose of levodopa(until Week36)
- CGS-S score
- CGS-I score(from the previous visit)
- PGS-S score
- PGS-I score(from the previous visit)
- Change in modified Hoehn & Yahr scale
- Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
- Change in Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
- Change in Parkinson's Disease Questionnaire (PDQ)-39 score
- Correlation among the score change presented
- Analysis of the motion, gait, sleeping using wearable device
研究者
标识符
- jRCT 编号
- jRCTs031180248
日期
- 首次提交
- (7年前)
- 最近更新
- (4年前)
相似试验
尚未招募
Unknown
同适应症Effect of auricular vagus nerve stimulation in Parkinson disease and freezing of GaitParkinson's disease.Parkinson's diseaseIRCT20121110011424N6Tehran University of Medical Sciences54
尚未招募
Unknown
同适应症Effect of three cueing devices (visual, auditory, and vibration) for people with Parkinson’s disease with freezing of gait difficultiesParkinson's disease.Parkinson's diseaseIRCT20240104060608N1Mashhad University of Medical Sciences25
招募中
Unknown
同适应症Effect of individualized exercise interventions versus control group on musculoskeletal disorders and quality of life in Parkinson's patientsParkinson's disease.Parkinson's diseaseIRCT20120215009014N519Hamedan University of Medical Sciences42
招募中
3 期
同适应症The effectiveness of Lavandula stoechas in Parkinson's diseaseParkinson's disease.Parkinson's diseaseIRCT20230505058093N1Kerman University of Medical Sciences30
终止
1 期
同适应症Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's DiseaseParkinson's DiseaseParkinson's Disease (PD)Parkinson's Disease (Disorder)NCT07348250Invicro16